• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Vivus

Vivus

  1. Vivus Inc. stock rises 4.6% after regaining certain commercial rights for Stendra from Sanofi

    Vivus Inc. stock rises 4.6% after regaining certain commercial rights for Stendra from Sanofi

  2. Top 3 Emerging Trends Impacting the Global Lifestyle Drugs Market from 2017-2021: Technavio

    Top 3 Emerging Trends Impacting the Global Lifestyle Drugs Market from 2017-2021: Technavio

©2017 Morningstar Advisor. All right reserved.